The Exposome in Rheumatoid Arthritis and Systemic Lupus Erythematosus: EXACT Network Planning
类风湿关节炎和系统性红斑狼疮的暴露组:精确的网络规划
基本信息
- 批准号:10869439
- 负责人:
- 金额:$ 44.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAir PollutionAntibodiesAreaAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmunityBiologicalBiological MarkersBiomedical ResearchChemicalsChronicClimateClinicalCollaborationsColoradoComplexDataData AnalysesData CollectionDatabasesDevelopmentDietDiseaseEnvironmental ExposureEnvironmental Risk FactorEtiologyEvolutionExhibitsExploratory/Developmental GrantFoodFoundationsFutureGenesGeneticGenetic RiskGoalsHealth FoodHormonesHuman Herpesvirus 4IndividualInflammationInflammatoryInfrastructureInterdisciplinary StudyLaboratoriesLife Cycle StagesMeasurementMeasuresMedicalMedical ResearchMethodsNatural HistoryObesityOccupationalOklahomaOmega-3 Fatty AcidsOutcomePatientsPesticidesPhasePlasmaPoliciesPopulationPreventionProcessProfessional OrganizationsProspective StudiesProspective cohortPsychosocial StressQuestionnairesRecording of previous eventsRegistriesResearchResearch PersonnelResearch Project GrantsResolutionResourcesRheumatoid ArthritisRiskRoleSamplingScienceSeverity of illnessSilicon DioxideSiteSmokingSocietal FactorsSourceSystemic Lupus ErythematosusTechniquesTestingTranslationsUniversitiesVitaminsWeatherWorkchemokineclinical developmentcohortcytokinedata integrationdesigndisorder riskepidemiology studygut microbiomehealth care availabilitylipid mediatorlung microbiomenoveloral microbiomeperipheral bloodpre-clinicalprospectiverepositoryseropositivesocialsymposium
项目摘要
PROJECT SUMMARY
This is an exploratory developmental grant aimed at the design, development, and implementation of a future
national, interdisciplinary, collaborative, team science research network that will advance the study of the
exposome in autoimmune diseases (Exposome in Autoimmune Diseases Collaborating Teams, EXACT). We
propose to plan a study of the exposome during the pre-clinical period of rheumatoid arthritis (RA) and
systemic lupus erythematosus (SLE). We assert that it is important to measure the exposome prior to the
development of disease to ensure that what we are measuring precedes the disease and is not a consequence
of the disease (which might happen if the exposome were measured in diseased individuals). This will allow us
to draw inference about the temporality and potential causality of exposures on the risk of RA and SLE. This
can be accomplished using prospective cohorts of at-risk individuals that are followed for the development of
clinical disease (ie classifiable RA and SLE) with which we have a long history of working. Investigators at the
University of Colorado Anschutz Medical Campus (Norris, Holers and Abraham) will work with investigators at
the Oklahoma Medical Research Foundation (James and Munroe) to conduct a landscape analysis of relevant
existing 1) resources, populations, databases, registries, repositories and consortia, 2) data on relevant
exposures, 3) exposome laboratories, and 4) exposome analytic techniques. This will provide a background
that we will use to plan activities for a new project to study the exposome in RA and SLE. As part of the
planning process, we will hold a summit of exposome experts and investigators with cohorts/populations of
individuals at-risk for RA and SLE, to develop and expand existing research collaborations to conduct a
prospective study in the exposome of these diseases. We will use our existing novel cohorts of at-risk
individuals who have been followed to the development of classifiable RA and SLE to explore feasibility of
harmonization of questionnaire and biomarker data and conduct secondary data analysis to support the
hypothesis and research strategy of the future EXACT Network. We will engage stakeholders such as scientific
or professional associations and patients and patient-advocates in the areas of RA and SLE for better
translation to inform the EXACT Network research agenda. The overall goal of this proposal is to plan research
strategies and develop partnerships, infrastructure, and capabilities needed to address the major goals of a
future collaborative EXACT network and to develop a research framework and strategies to support
coordination among studies, collaborative research projects, and sites. Specific Aim 1. To conduct a
multipronged approach to determine the needs and currently available resources to prospectively and
effectively measure the exposome in RA and SLE (via a landscape analysis). Specific Aim 2. To design a
prospective study to examine the role of the exposome in the etiology of RA and SLE, with an interdisciplinary
research team, rigorous exposome measurements and novel analytic approaches.
项目总结
这是一项探索性发展拨款,旨在设计、开发和实施未来
国家、跨学科、协作、团队科学研究网络,将推动对
自身免疫性疾病中的暴露体(自身免疫性疾病中的暴露体合作小组,Exposome)。我们
建议计划对类风湿性关节炎(RA)临床前阶段的暴露组进行研究
系统性红斑狼疮(SLE)。我们断言,在曝光之前测量曝光体是很重要的
疾病的发展,以确保我们正在测量的东西在疾病之前,而不是结果
(如果对患病个体进行测量,则可能会发生这种情况)。这将使我们能够
对暴露于类风湿关节炎和系统性红斑狼疮风险的暂时性和潜在因果关系进行推断。这
可以使用预期的高危个体队列来实现,这些高危个体被跟踪以发展
临床疾病(即可分类的类风湿性关节炎和系统性红斑狼疮),我们有很长的工作历史。该中心的调查人员
科罗拉多大学安舒茨医学院(诺里斯、霍勒斯和亚伯拉罕)将与调查人员在
俄克拉荷马医学研究基金会(詹姆斯和门罗)对相关的景观进行分析
现有1)资源、人口、数据库、登记册、储存库和联合体,2)有关数据
曝光,3)曝光组实验室,4)曝光组分析技术。这将提供一个背景
我们将用它来计划一个新项目的活动,以研究RA和SLE的曝光组。作为该计划的一部分
规划过程中,我们将举行一次揭露专家和调查人员与队列/人口的峰会
风湿性关节炎和系统性红斑狼疮的高危人群,发展和扩大现有的研究合作,以进行
这些疾病暴露的前瞻性研究。我们将利用我们现有的新的风险队列
被跟踪发展成可分类的类风湿关节炎和系统性红斑狼疮以探索
统一调查问卷和生物标志物数据,并进行二级数据分析,以支持
未来精确网络的假设和研究策略。我们将与科学公司等利益攸关方接触
或在类风湿性关节炎和系统性红斑狼疮领域的专业协会和患者和患者倡导者
翻译为准确的网络研究议程提供信息。这项提案的总体目标是计划研究
战略和发展合作伙伴关系、基础设施和能力,以实现
未来协作确切的网络,并制定支持研究框架和策略
研究、协作研究项目和站点之间的协调。具体目标1.开展一项
多管齐下,以确定需求和目前可用的资源,以前瞻性和
有效测量类风湿性关节炎和系统性红斑狼疮的曝光体(通过景观分析)。具体目标2.设计一种
一项跨学科的前瞻性研究,探讨暴露组在类风湿关节炎和系统性红斑狼疮病因中的作用
研究团队、严格的曝光测量和新颖的分析方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JILL M NORRIS其他文献
JILL M NORRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JILL M NORRIS', 18)}}的其他基金
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 44.9万 - 项目类别:
Nutrigenetics & -genomics of Vitamin D and Omega-3 Fatty Acids in Type 1 Diabetes
营养遗传学
- 批准号:
9119814 - 财政年份:2014
- 资助金额:
$ 44.9万 - 项目类别:
Nutrigenetics & -genomics of Vitamin D and Omega-3 Fatty Acids in Type 1 Diabetes
营养遗传学
- 批准号:
8825658 - 财政年份:2014
- 资助金额:
$ 44.9万 - 项目类别:
RA-Related Autoantibodies in Healthy FDR of RA Patients
RA 患者健康 FDR 中的 RA 相关自身抗体
- 批准号:
7651103 - 财政年份:2005
- 资助金额:
$ 44.9万 - 项目类别:
RA-Related Autoantibodies in Healthy FDR of RA Patients
RA 患者健康 FDR 中的 RA 相关自身抗体
- 批准号:
8324330 - 财政年份:2005
- 资助金额:
$ 44.9万 - 项目类别:
IRAS FAMILY STUDY--GENETICS OF INSULIN RESISTANCE
IRAS 家族研究——胰岛素抵抗的遗传学
- 批准号:
6390060 - 财政年份:1999
- 资助金额:
$ 44.9万 - 项目类别:
GENE ENVIRONMENT STUDY OF TYPE 2 DIABETES IN FAMILIES
2型糖尿病家族基因环境研究
- 批准号:
2900351 - 财政年份:1999
- 资助金额:
$ 44.9万 - 项目类别:
GENE ENVIRONMENT STUDY OF TYPE 2 DIABETES IN FAMILIES
2型糖尿病家族基因环境研究
- 批准号:
6523766 - 财政年份:1999
- 资助金额:
$ 44.9万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 44.9万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 44.9万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 44.9万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 44.9万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 44.9万 - 项目类别: